Bristol-Myers Exec Dug Own Grave With Cover-Up Efforts

Law360, New York (August 3, 2012, 8:29 PM EDT) -- Before he allegedly traded on inside information about his employer's potential acquisitions, an executive at Bristol-Myers Squibb Co. searched Yahoo for ways to hide his crime, showing how even supposedly sophisticated defendants can end up damning themselves when trying to cover their tracks, experts say.

Robert Ramnarine, an assistant treasurer for capital markets at the pharmaceutical giant, allegedly bought stock options in three BMS acquisition targets — ZymoGenetics Inc., Pharmasset Inc. and Amylin Pharmaceuticals Inc. — based on private information he learned through his job, according...
To view the full article, register now.